Two-Year Neurodevelopment and Growth Outcomes for Preterm Neonates Who Received Low-Dose Intravenous Soybean Oil

Ong, M. L.; Purdy, I. B.; Levit, O. L.; Robinson, D. T.; Grogan, T.; Flores, M.; Calkins, K. L.

JPEN J Parenter Enteral Nutr. 2018 Feb 15; 42(2):352-360

Abstract

BACKGROUND: In some studies, the dose of intravenous soybean oil (SO) has been associated with a decreased incidence of intestinal failure-associated liver disease. The effect of lipid sparing on neurodevelopment (ND) and growth remains unknown. This study investigated the impact of SO dose on ND and growth over the first 2 years of age in preterm neonates. MATERIALS AND METHODS: This is a single-site prospective follow-up study. Neonates with a gestational age

Read More on PubMed